1. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Jama 288: 2981–2997, 2002
2. Alderman MH. Allhat and beyond. Am J Hypertens 16: 512–514, 2003
3. Andre-Fouet X, Usdin JP, Gayet C, Wilner C, Thizy JF, Viallet M, Apoil E, Vernant P and Pont M. Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest—a randomized trial in 70 patients. Eur Heart J 4: 691–698, 1983
4. Bambauer R, Jutzler GA, Weber U, Walter R and Keller HE. Nitrendipine in patients with end-stage renal disease and hypertension. J Cardiovasc Pharmacol 12 Suppl 4: S 133–135, 1988
5. Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, Mancia G, Neal B, Whitworth J and Zanchetti A. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 21: 665–672, 2003